Growth Metrics

AbCellera Biologics (ABCL) Shares Outstanding (Diluted Average) (2022 - 2026)

AbCellera Biologics filings provide 5 years of Shares Outstanding (Diluted Average) readings, the most recent being $303.1 million for Q1 2026.